Showing results (171-180 of 177) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
American Journal of Respiratory and Critical Care Medicine|June 25, 2026
The frequent exacerbator phenotype in bronchiectasis revisited: Data from EMBARC registryOriol Sibila, Lidia Perea, Pierre Regis Burgel, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2012
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activationJin-Fu Xu, George R Washko, Kiichi Nakahira, et al.
ERJ Open Research|February 27, 2024
A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASEYong-Hua Gao, Hai-Wen Lu, Hui-Zhen Zheng, et al.
The Lancet. Respiratory Medicine|January 13, 2025
Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort studyJin-Fu Xu, Hui-Zhen Zheng, Hai-Wen Lu, et al.
The Lancet. Digital Health|June 6, 2020
Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort studyBei Mao, Yang Liu, Yan-Hua Chai, et al.
The Lancet. Respiratory Medicine|August 30, 2025
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational studyOriol Sibila, Jamie Stobo, Lidia Perea, et al.
The Lancet. Respiratory Medicine|May 19, 2026
Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registriesRebecca C Hull, Yang Liu, Zu Cao, et al.
Pageof 18